160 related articles for article (PubMed ID: 21889718)
1. Hormonal modulation in the treatment of breast cancer.
Adelson K; Germain D; Raptis G; Biran N
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):519-32, viii. PubMed ID: 21889718
[TBL] [Abstract][Full Text] [Related]
2. New approaches to reverse resistance to hormonal therapy in human breast cancer.
Weinberg OK; Marquez-Garban DC; Pietras RJ
Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
[TBL] [Abstract][Full Text] [Related]
3. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
Bodmer A; Castiglione-Gertsch M
Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
[No Abstract] [Full Text] [Related]
4. Evolution of endocrine adjuvant therapy for early breast cancer.
Lønning PE
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S19-30. PubMed ID: 20374026
[TBL] [Abstract][Full Text] [Related]
5. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
6. Management of bone disease in patients undergoing hormonal therapy for breast cancer.
Mirza FS
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):549-62, viii. PubMed ID: 21889720
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy for advanced breast cancer.
Rugo HS
Hematol Oncol Clin North Am; 2007 Apr; 21(2):273-91. PubMed ID: 17512449
[TBL] [Abstract][Full Text] [Related]
8. [Biomarkers of endocrine therapy-resistance in breast cancers].
de Cremoux P; Debled M; Bonnefoi H; Cottu P
Bull Cancer; 2010 Aug; 97(8):951-63. PubMed ID: 20605764
[TBL] [Abstract][Full Text] [Related]
9. Endocrine therapy resistance: current status, possible mechanisms and overcoming strategies.
Chang J; Fan W
Anticancer Agents Med Chem; 2013 Mar; 13(3):464-75. PubMed ID: 22931419
[TBL] [Abstract][Full Text] [Related]
10. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
Tokunaga E; Kataoka A; Kimura Y; Oki E; Mashino K; Nishida K; Koga T; Morita M; Kakeji Y; Baba H; Ohno S; Maehara Y
Eur J Cancer; 2006 Mar; 42(5):629-35. PubMed ID: 16464571
[TBL] [Abstract][Full Text] [Related]
11. Endocrine therapy and other targeted therapies for metastatic breast cancer.
Hussain SA; Palmer DH; Moon S; Rea DW
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors: future directions.
Osborne CK; Schiff R
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):183-7. PubMed ID: 16019204
[TBL] [Abstract][Full Text] [Related]
13. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
Bedard PL; Freedman OC; Howell A; Clemons M
Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
[TBL] [Abstract][Full Text] [Related]
14. Addressing the future: combination with targeted therapies, adjuvant setting and beyond.
Goss PE
Anticancer Drugs; 2008 Mar; 19 Suppl 2():S3-5. PubMed ID: 18337641
[TBL] [Abstract][Full Text] [Related]
15. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
Dixon JM
Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
[TBL] [Abstract][Full Text] [Related]
16. Recent topics in endocrine therapy for hormone-dependent breast cancer: basic research and clinical applications.
Kimijima I
Breast Cancer; 2008; 15(4):253-5. PubMed ID: 18953680
[No Abstract] [Full Text] [Related]
17. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
Cunnick G; Mokbel K
Int J Fertil Womens Med; 2005; 50(5 Pt 1):197-8. PubMed ID: 16468468
[TBL] [Abstract][Full Text] [Related]
18. [Surviving resistance to hormone therapy in hormone-dependent metastatic breast carcinoma].
Tesarova P
Klin Onkol; 2012; 25(6):486-8. PubMed ID: 23346638
[No Abstract] [Full Text] [Related]
19. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
20. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
Massarweh S; Schiff R
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]